Search - tctmd.com

Displaying 301 - 320 of 350

Sort: Relevancy | Date

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

News Industry News

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

May 21, 2014

News Industry News

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

May 07, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

News Industry News

Abbott's First-of-Its-Kind MitraClip® Device Now Approved in Canada

April 30, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Industry News

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

March 24, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Las Nuevas Directrices sobre el Manejo de la Cardiopatía Valvular Integran Intervenciones basadas en Catéteres

L.A. McKeown

March 20, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

News Conference News TCT 2013

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Conference News TCT 2013

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

October 28, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

Yael L. Maxwell

August 09, 2013

News Daily News

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

L.A. McKeown

April 05, 2013

News Industry News

St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial

February 03, 2013

Advertisement

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Abbott's First-of-Its-Kind MitraClip® Device Now Approved in Canada

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Las Nuevas Directrices sobre el Manejo de la Cardiopatía Valvular Integran Intervenciones basadas en Catéteres

Survival After Septal Ablation for HOCM Similar to General Population

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content